| Year |
Citation |
Score |
| 2020 |
Spatola M, Pedrol MP, Maudes E, Simabukuro M, Muñiz-Castrillo S, Pinto AL, Wandinger KP, Spiegler J, Schramm P, Dutra LA, Iorio R, Kornblum C, Bien CG, Höftberger R, Leypoldt F, ... ... Rosenfeld MR, et al. Clinical features, prognostic factors, and antibody effects in anti-mGluR1 encephalitis. Neurology. PMID 32928978 DOI: 10.1212/Wnl.0000000000010854 |
0.355 |
|
| 2019 |
Dalmau J, Armangué T, Planagumà J, Radosevic M, Mannara F, Leypoldt F, Geis C, Lancaster E, Titulaer MJ, Rosenfeld MR, Graus F. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. The Lancet. Neurology. PMID 31326280 DOI: 10.1016/S1474-4422(19)30244-3 |
0.358 |
|
| 2018 |
Blakeley JO, Grossman SA, Chi AS, Mikkelsen T, Rosenfeld MR, Ahluwalia MS, Nabors LB, Eichler A, Garcia-Ribas I, Desideri S, Ye X. Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed Glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30131387 DOI: 10.1158/1078-0432.Ccr-18-0110 |
0.304 |
|
| 2018 |
Spatola M, Sabater L, Planagumà J, Martínez-Hernandez E, Armangué T, Prüss H, Iizuka T, Caparó Oblitas RL, Antoine JC, Li R, Heaney N, Tubridy N, Munteis Olivas E, Rosenfeld MR, Graus F, et al. Encephalitis with mGluR5 antibodies: Symptoms and antibody effects. Neurology. PMID 29703767 DOI: 10.1212/Wnl.0000000000005614 |
0.372 |
|
| 2018 |
Hara M, Martinez-Hernandez E, Ariño H, Armangué T, Spatola M, Petit-Pedrol M, Saiz A, Rosenfeld MR, Graus F, Dalmau J. Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor. Neurology. PMID 29549218 DOI: 10.1212/Wnl.0000000000005329 |
0.363 |
|
| 2017 |
Hara M, Ariño H, Petit-Pedrol M, Sabater L, Titulaer MJ, Martinez-Hernandez E, Schreurs MW, Rosenfeld MR, Graus F, Dalmau J. DPPX antibody-associated encephalitis: Main syndrome and antibody effects. Neurology. PMID 28258082 DOI: 10.1212/Wnl.0000000000003796 |
0.357 |
|
| 2017 |
Spatola M, Petit-Pedrol M, Simabukuro MM, Armangue T, Castro FJ, Barcelo Artigues MI, Julià Benique MR, Benson L, Gorman M, Felipe A, Caparó Oblitas RL, Rosenfeld MR, Graus F, Dalmau J. Investigations in GABAA receptor antibody-associated encephalitis. Neurology. PMID 28202703 DOI: 10.1212/Wnl.0000000000003713 |
0.342 |
|
| 2016 |
Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, Glaser CA, Honnorat J, Höftberger R, Iizuka T, Irani SR, ... ... Rosenfeld MR, et al. A clinical approach to diagnosis of autoimmune encephalitis. The Lancet. Neurology. PMID 26906964 DOI: 10.1016/S1474-4422(15)00401-9 |
0.328 |
|
| 2015 |
Armangue T, Moris G, Cantarín-Extremera V, Conde CE, Rostasy K, Erro ME, Portilla-Cuenca JC, Turón-Viñas E, Málaga I, Muñoz-Cabello B, Torres-Torres C, Llufriu S, González-Gutiérrez-Solana L, González G, Casado-Naranjo I, ... Rosenfeld M, et al. Autoimmune post-herpes simplex encephalitis of adults and teenagers. Neurology. PMID 26491084 DOI: 10.1212/Wnl.0000000000002125 |
0.381 |
|
| 2015 |
Höftberger R, Rosenfeld MR, Dalmau J. Update on neurological paraneoplastic syndromes. Current Opinion in Oncology. 27: 489-95. PMID 26335665 DOI: 10.1097/Cco.0000000000000222 |
0.304 |
|
| 2014 |
Rosenfeld MR. Antibody-mediated central nervous system diseases: disease recognition and treatment challenges. Clinical and Experimental Immunology. 178: 30-2. PMID 25546752 DOI: 10.1111/Cei.12501 |
0.423 |
|
| 2014 |
Linnoila JJ, Rosenfeld MR, Dalmau J. Neuronal surface antibody-mediated autoimmune encephalitis. Seminars in Neurology. 34: 458-66. PMID 25369441 DOI: 10.1055/S-0034-1390394 |
0.422 |
|
| 2014 |
Rosenfeld MR, Ye X, Supko JG, Desideri S, Grossman SA, Brem S, Mikkelson T, Wang D, Chang YC, Hu J, McAfee Q, Fisher J, Troxel AB, Piao S, Heitjan DF, et al. A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme. Autophagy. 10: 1359-68. PMID 24991840 DOI: 10.4161/Auto.28984 |
0.307 |
|
| 2014 |
Titulaer MJ, Höftberger R, Iizuka T, Leypoldt F, McCracken L, Cellucci T, Benson LA, Shu H, Irioka T, Hirano M, Singh G, Cobo Calvo A, Kaida K, Morales PS, Wirtz PW, ... ... Rosenfeld MR, et al. Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis. Annals of Neurology. 75: 411-28. PMID 24700511 DOI: 10.1002/Ana.24117 |
0.412 |
|
| 2014 |
Dalmau J, Rosenfeld MR. Autoimmune encephalitis update. Neuro-Oncology. 16: 771-8. PMID 24637228 DOI: 10.1093/Neuonc/Nou030 |
0.391 |
|
| 2014 |
Gresa-Arribas N, Titulaer MJ, Torrents A, Aguilar E, McCracken L, Leypoldt F, Gleichman AJ, Balice-Gordon R, Rosenfeld MR, Lynch D, Graus F, Dalmau J. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. The Lancet. Neurology. 13: 167-77. PMID 24360484 DOI: 10.1016/S1474-4422(13)70282-5 |
0.393 |
|
| 2013 |
Pruitt AA, Graus F, Rosenfeld MR. Neurological complications of transplantation: part I: hematopoietic cell transplantation. The Neurohospitalist. 3: 24-38. PMID 23983885 DOI: 10.1177/1941874412455338 |
0.301 |
|
| 2013 |
Titulaer MJ, McCracken L, Gabilondo I, Iizuka T, Kawachi I, Bataller L, Torrents A, Rosenfeld MR, Balice-Gordon R, Graus F, Dalmau J. Late-onset anti-NMDA receptor encephalitis. Neurology. 81: 1058-63. PMID 23946310 DOI: 10.1212/Wnl.0B013E3182A4A49C |
0.34 |
|
| 2013 |
Rosenfeld MR, Dalmau J. Diagnosis and management of paraneoplastic neurologic disorders. Current Treatment Options in Oncology. 14: 528-38. PMID 23900965 DOI: 10.1007/S11864-013-0249-1 |
0.41 |
|
| 2013 |
Peereboom DM, Ahluwalia MS, Ye X, Supko JG, Hilderbrand SL, Phuphanich S, Nabors LB, Rosenfeld MR, Mikkelsen T, Grossman SA. NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiforme. Neuro-Oncology. 15: 490-6. PMID 23328813 DOI: 10.1093/Neuonc/Nos322 |
0.304 |
|
| 2013 |
Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, Iizuka T, Honig LS, Benseler SM, Kawachi I, Martinez-Hernandez E, Aguilar E, Gresa-Arribas N, Ryan-Florance N, Torrents A, Saiz A, ... Rosenfeld MR, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. The Lancet. Neurology. 12: 157-65. PMID 23290630 DOI: 10.1016/S1474-4422(12)70310-1 |
0.359 |
|
| 2013 |
Boronat A, Gelfand JM, Gresa-Arribas N, Jeong HY, Walsh M, Roberts K, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R, Graus F, Rudy B, Dalmau J. Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels. Annals of Neurology. 73: 120-8. PMID 23225603 DOI: 10.1002/Ana.23756 |
0.409 |
|
| 2012 |
Rosenfeld MR, Titulaer MJ, Dalmau J. Paraneoplastic syndromes and autoimmune encephalitis: Five new things. Neurology. Clinical Practice. 2: 215-223. PMID 23634368 DOI: 10.1212/CPJ.0b013e31826af23e |
0.305 |
|
| 2012 |
Rosenfeld MR, Dalmau J. Paraneoplastic Neurologic Disorders: A Brief Overview. Memo. 5: 197-200. PMID 23264806 DOI: 10.1007/S12254-012-0034-Z |
0.396 |
|
| 2012 |
Nabors LB, Mikkelsen T, Hegi ME, Ye X, Batchelor T, Lesser G, Peereboom D, Rosenfeld MR, Olsen J, Brem S, Fisher JD, Grossman SA. A safety run-in and randomized phase 2 study of cilengitide combined with chemoradiation for newly diagnosed glioblastoma (NABTT 0306). Cancer. 118: 5601-7. PMID 22517399 DOI: 10.1002/Cncr.27585 |
0.333 |
|
| 2012 |
Grossman SA, Ye X, Peereboom D, Rosenfeld MR, Mikkelsen T, Supko JG, Desideri S. Phase I study of terameprocol in patients with recurrent high-grade glioma. Neuro-Oncology. 14: 511-7. PMID 22323663 DOI: 10.1093/Neuonc/Nor230 |
0.32 |
|
| 2012 |
Martinez-Garcia M, Rosenfeld MR. Recent developments in the treatment of high-grade gliomas Community Oncology. 9: 307-314. DOI: 10.1016/J.Cmonc.2012.09.007 |
0.326 |
|
| 2011 |
Nabors LB, Supko JG, Rosenfeld M, Chamberlain M, Phuphanich S, Batchelor T, Desideri S, Ye X, Wright J, Gujar S, Grossman SA. Phase I trial of sorafenib in patients with recurrent or progressive malignant glioma Neuro-Oncology. 13: 1324-1330. PMID 21954442 DOI: 10.1093/Neuonc/Nor145 |
0.311 |
|
| 2011 |
Dalmau J, Rosenfeld MR. Paraneoplastic syndromes causing movement disorders. Handbook of Clinical Neurology. 100: 315-21. PMID 21496591 DOI: 10.1016/B978-0-444-52014-2.00024-0 |
0.377 |
|
| 2011 |
Rosenfeld MR, Dalmau J. Anti-NMDA-Receptor Encephalitis and Other Synaptic Autoimmune Disorders. Current Treatment Options in Neurology. 13: 324-32. PMID 21298406 DOI: 10.1007/S11940-011-0116-Y |
0.383 |
|
| 2011 |
Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. The Lancet. Neurology. 10: 63-74. PMID 21163445 DOI: 10.1016/S1474-4422(10)70253-2 |
0.414 |
|
| 2011 |
Arratibel-Echarren I, Albright K, Dalmau J, Rosenfeld MR. Use of Bevacizumab for neurological complications during initial treatment of malignant gliomas | Utilización de bevacizumab en las complicaciones neurológicas durante el tratamiento inicial de los gliomas malignos Neurologia. 26: 74-80. PMID 21163238 DOI: 10.1016/J.Nrl.2010.05.010 |
0.358 |
|
| 2011 |
Arratibel-Echarren I, Albright K, Dalmau J, Rosenfeld MR. Use of Bevacizumab for neurological complications during initial treatment of malignant gliomas Neurologia. 26: 74-80. DOI: 10.1016/S2173-5808(11)70017-7 |
0.356 |
|
| 2011 |
Rosenfeld MR, Albright K, Pruitt AA. Treatment of recurrent high-grade gliomas Community Oncology. 8: 171-177. DOI: 10.1016/S1548-5315(12)70068-2 |
0.302 |
|
| 2010 |
González-Valcárcel J, Rosenfeld MR, Dalmau J. Differential diagnosis of encephalitis due to anti-NMDA receptor antibodies Neurologia. 25: 409-413. PMID 20964986 DOI: 10.1016/S2173-5808(10)70077-8 |
0.396 |
|
| 2010 |
Rosenfeld MR, Chamberlain MC, Grossman SA, Peereboom DM, Lesser GJ, Batchelor TT, Desideri S, Salazar AM, Ye X. A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma. Neuro-Oncology. 12: 1071-7. PMID 20615924 DOI: 10.1093/Neuonc/Noq071 |
0.368 |
|
| 2010 |
Rosenfeld MR, Dalmau J. Update on paraneoplastic and autoimmune disorders of the central nervous system. Seminars in Neurology. 30: 320-31. PMID 20577938 DOI: 10.1055/S-0030-1255223 |
0.409 |
|
| 2010 |
Rosenfeld MR, Dalmau J. Update on paraneoplastic neurologic disorders. The Oncologist. 15: 603-17. PMID 20479279 DOI: 10.1634/Theoncologist.2010-0001 |
0.337 |
|
| 2010 |
Grossman SA, Ye X, Piantadosi S, Desideri S, Nabors LB, Rosenfeld M, Fisher J. Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 2443-9. PMID 20371685 DOI: 10.1158/1078-0432.Ccr-09-3106 |
0.329 |
|
| 2009 |
Nabors LB, Mikkelsen T, Batchelor T, Lesser G, Rosenfeld M, Ye X, Piantadosi S, Olson J, Brem S, Grossman S. NABTT 0306: A randomized phase II trial of EMD 121974 in conjunction with concomitant and adjuvant temozolomide with radiation therapy in patients with newly diagnosed glioblastoma multiforme (GBM). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 2001. PMID 27964566 DOI: 10.1200/Jco.2009.27.15_Suppl.2001 |
0.313 |
|
| 2009 |
Rosenfeld MR, Chamberlain M, Grossman SA, Peereboom DM, Lesser GJ, Batchelor TT, Desideri S, Salazar AM, Ye X. A phase II study of chemoradiation followed by adjuvant temozolomide and poly-ICLC in patients with newly diagnosed glioblastoma: 12- and 18-month survival data (NABTT 0501). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 2002. PMID 27964563 DOI: 10.1200/Jco.2009.27.15_Suppl.2002 |
0.32 |
|
| 2009 |
Tüzün E, Zhou L, Baehring JM, Bannykh S, Rosenfeld MR, Dalmau J. Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma. Acta Neuropathologica. 118: 737-43. PMID 19680671 DOI: 10.1007/S00401-009-0582-4 |
0.412 |
|
| 2009 |
Florance NR, Davis RL, Lam C, Szperka C, Zhou L, Ahmad S, Campen CJ, Moss H, Peter N, Gleichman AJ, Glaser CA, Lynch DR, Rosenfeld MR, Dalmau J. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Annals of Neurology. 66: 11-8. PMID 19670433 DOI: 10.1002/Ana.21756 |
0.342 |
|
| 2008 |
Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R, Lynch DR. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. The Lancet. Neurology. 7: 1091-8. PMID 18851928 DOI: 10.1016/S1474-4422(08)70224-2 |
0.416 |
|
| 2008 |
Dalmau J, Rosenfeld MR. Paraneoplastic syndromes of the CNS. The Lancet. Neurology. 7: 327-40. PMID 18339348 DOI: 10.1016/S1474-4422(08)70060-7 |
0.338 |
|
| 2008 |
Rosenfeld MR, Dalmau J. Paraneoplastic syndromes of the nervous system Cancer Neurology in Clinical Practice: Neurologic Complications of Cancer and Its Treatment: Second Edition. 237-255. DOI: 10.1007/978-1-59745-412-4_15 |
0.354 |
|
| 2007 |
Kranick SM, Mowry EM, Rosenfeld MR. Progressive multifocal leukoencephalopathy after rituximab in a case of non-Hodgkin lymphoma. Neurology. 69: 704-6. PMID 17698796 DOI: 10.1212/01.Wnl.0000267325.06000.D9 |
0.317 |
|
| 2007 |
Dalmau J, Tüzün E, Wu HY, Masjuan J, Rossi JE, Voloschin A, Baehring JM, Shimazaki H, Koide R, King D, Mason W, Sansing LH, Dichter MA, Rosenfeld MR, Lynch DR. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Annals of Neurology. 61: 25-36. PMID 17262855 DOI: 10.1002/Ana.21050 |
0.433 |
|
| 2007 |
Mathew RM, Vandenberghe R, Garcia-Merino A, Yamamoto T, Landolfi JC, Rosenfeld MR, Rossi JE, Thiessen B, Dropcho EJ, Dalmau J. Orchiectomy for suspected microscopic tumor in patients with anti-Ma2-associated encephalitis Neurology. 68: 900-905. PMID 17151337 DOI: 10.1212/01.Wnl.0000252379.81933.80 |
0.405 |
|
| 2007 |
Nabors LB, Rosenfeld M, Chamberlain M, Phuphanich S, Batchelor T, Supko J, Desideri S, Xiaobu Y, Wright J, Grossman S. A phase I trial of sorafenib (BAY 43-9006) for patients with recurrent or progressive malignant glioma (NABTT 0401) Journal of Clinical Oncology. 25: 2058-2058. DOI: 10.1200/Jco.2007.25.18_Suppl.2058 |
0.324 |
|
| 2007 |
Bataller L, Kleopa KA, Wu GF, Rossi JE, Rosenfeld MR, Dalmau J. Autoimmune limbic encephalitis in 39 patients: Immunophenotypes and outcomes Journal of Neurology, Neurosurgery and Psychiatry. 78: 381-385. DOI: 10.1136/Jnnp.2006.100644 |
0.423 |
|
| 2007 |
Rosenfeld MR, Dalmau J. Paraneoplastic limbic encephalitis associated with small-cell lung cancer Community Oncology. 4: 491-494. DOI: 10.1016/S1548-5315(11)70483-1 |
0.38 |
|
| 2007 |
Rosenfeld MR, Pruitt AA. Managing medical complications in patients with brain tumors Community Oncology. 4: 411-416. DOI: 10.1016/S1548-5315(11)70149-8 |
0.315 |
|
| 2006 |
Rosenfeld MR, Dalmau J. Current therapies for neuromuscular manifestations of paraneoplastic syndromes. Current Neurology and Neuroscience Reports. 6: 77-84. PMID 16469274 DOI: 10.1007/S11910-996-0012-0 |
0.404 |
|
| 2005 |
Ances BM, Vitaliani R, Taylor RA, Liebeskind DS, Voloschin A, Houghton DJ, Galetta SL, Dichter M, Alavi A, Rosenfeld MR, Dalmau J. Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain : a Journal of Neurology. 128: 1764-77. PMID 15888538 DOI: 10.1093/Brain/Awh526 |
0.429 |
|
| 2004 |
Dalmau J, Graus F, Villarejo A, Posner JB, Blumenthal D, Thiessen B, Saiz A, Meneses P, Rosenfeld MR. Clinical analysis of anti-Ma2-associated encephalitis. Brain : a Journal of Neurology. 127: 1831-44. PMID 15215214 DOI: 10.1093/Brain/Awh203 |
0.42 |
|
| 2004 |
Bataller L, Wade DF, Graus F, Stacey HD, Rosenfeld MR, Dalmau J. Antibodies to Zic4 in paraneoplastic neurologic disorders and small-cell lung cancer Neurology. 62: 778-782. PMID 15007130 DOI: 10.1212/01.Wnl.0000113749.77217.01 |
0.434 |
|
| 2003 |
Bataller L, Rosenfeld MR, Graus F, Vilchez JJ, Cheung NK, Dalmau J. Autoantigen diversity in the opsoclonus-myoclonus syndrome. Annals of Neurology. 53: 347-53. PMID 12601702 DOI: 10.1002/Ana.10462 |
0.377 |
|
| 2003 |
Rosenfeld MR, Dalmau J. Current Therapies for Paraneoplastic Neurologic Syndromes. Current Treatment Options in Neurology. 5: 69-77. PMID 12521564 DOI: 10.1007/S11940-003-0023-Y |
0.399 |
|
| 2003 |
Bataller L, Wade DF, Graus F, Rosenfeld MR, Dalmau J. The MAZ protein is an autoantigen of Hodgkin's disease and paraneoplastic cerebellar dysfunction. Annals of Neurology. 53: 123-7. PMID 12509857 DOI: 10.1002/Ana.10434 |
0.374 |
|
| 2002 |
Bataller L, Wade DF, Fuller GN, Rosenfeld MR, Dalmau J. Cerebellar degeneration and autoimmunity to zinc-finger proteins of the cerebellum. Neurology. 59: 1985-7. PMID 12499499 DOI: 10.1212/01.Wnl.0000038352.01415.Ce |
0.343 |
|
| 2001 |
Rosenfeld MR, Dalmau J. The clinical spectrum and pathogenesis of paraneoplastic disorders of the central nervous system Hematology/Oncology Clinics of North America. 15: 1109-1128. PMID 11770301 DOI: 10.1016/S0889-8588(05)70270-7 |
0.357 |
|
| 2001 |
Eichen JG, Dalmau J, Demopoulos A, Wade D, Posner JB, Rosenfeld MR. The photoreceptor cell-specific nuclear receptor is an autoantigen of paraneoplastic retinopathy. Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society. 21: 168-72. PMID 11725181 DOI: 10.1097/00041327-200109000-00003 |
0.711 |
|
| 2001 |
Rosenfeld MR, Eichen JG, Wade DF, Posner JB, Dalmau J. Molecular and clinical diversity in paraneoplastic immunity to Ma proteins. Annals of Neurology. 50: 339-48. PMID 11558790 DOI: 10.1002/Ana.1288 |
0.415 |
|
| 2000 |
Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain : a Journal of Neurology. 123: 1481-94. PMID 10869059 DOI: 10.1093/Brain/123.7.1481 |
0.417 |
|
| 1999 |
Dalmau J, Gultekin SH, Voltz R, Hoard R, DesChamps T, Balmaceda C, Batchelor T, Gerstner E, Eichen J, Frennier J, Posner JB, Rosenfeld MR. Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders. Brain : a Journal of Neurology. 122: 27-39. PMID 10050892 DOI: 10.1093/Brain/122.1.27 |
0.439 |
|
| 1999 |
Voltz R, Carpentier AF, Rosenfeld MR, Posner JB, Dalmau J. P/Q-type voltage-gated calcium channel antibodies in paraneoplastic disorders of the central nervous system. Muscle & Nerve. 22: 119-22. PMID 9883867 DOI: 10.1002/(Sici)1097-4598(199901)22:1<119::Aid-Mus19>3.0.Co;2-5 |
0.395 |
|
| 1998 |
Khakoo Y, Rosenfeld MR. Understanding regulation of cell growth in childhood brain tumors Current Opinion in Pediatrics. 10: 551-555. PMID 9848011 DOI: 10.1097/00008480-199810060-00002 |
0.3 |
|
| 1998 |
Voltz R, Dalmau J, Posner JB, Rosenfeld MR. T-cell receptor analysis in anti-Hu associated paraneoplastic encephalomyelitis. Neurology. 51: 1146-50. PMID 9781545 DOI: 10.1212/Wnl.51.4.1146 |
0.374 |
|
| 1998 |
Levin MC, Krichavsky M, Berk J, Foley S, Rosenfeld M, Dalmau J, Chang G, Posner JB, Jacobson S. Neuronal molecular mimicry in immune-mediated neurologic disease. Annals of Neurology. 44: 87-98. PMID 9667596 DOI: 10.1002/Ana.410440115 |
0.391 |
|
| 1998 |
Degenhardt A, Duvoisin RM, Frennier J, Gultekin SH, Rosenfeld MR, Posner JB, Dalmau J. Absence of antibodies to non-NMDA glutamate-receptor subunits in paraneoplastic cerebellar degeneration. Neurology. 50: 1392-7. PMID 9595993 DOI: 10.1212/Wnl.50.5.1392 |
0.408 |
|
| 1998 |
Verschuuren JJ, Dalmau J, Tunkel R, Lang B, Graus F, Schramm L, Posner JB, Newsom-Davis J, Rosenfeld MR. Antibodies against the calcium channel beta-subunit in Lambert-Eaton myasthenic syndrome. Neurology. 50: 475-9. PMID 9484375 DOI: 10.1212/Wnl.50.2.475 |
0.348 |
|
| 1997 |
Mason WP, Graus F, Lang B, Honnorat J, Delattre JY, Valldeoriola F, Antoine JC, Rosenblum MK, Rosenfeld MR, Newsom-Davis J, Posner JB, Dalmau J. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain : a Journal of Neurology. 120: 1279-300. PMID 9278623 DOI: 10.1093/Brain/120.8.1279 |
0.405 |
|
| 1997 |
Rosenfeld MR, Malats N, Schramm L, Graus F, Cardenal F, Viñolas N, Rosell R, Torà M, Real FX, Posner JB, Dalmau J. Serum anti-p53 antibodies and prognosis of patients with small-cell lung cancer. Journal of the National Cancer Institute. 89: 381-5. PMID 9060960 DOI: 10.1093/Jnci/89.5.381 |
0.385 |
|
| 1996 |
Morita M, Rosenblum MK, Bilsky MH, Fraser RA, Rosenfeld MR. Long-term survivors of glioblastoma multiforme: clinical and molecular characteristics. Journal of Neuro-Oncology. 27: 259-66. PMID 8847560 DOI: 10.1007/Bf00165483 |
0.318 |
|
| 1995 |
Dalmau J, Rosenfeld MR. [16] Characterization of neuronal antigens and antineuronal antibodies Methods in Neurosciences. 24: 261-271. DOI: 10.1016/S1043-9471(06)80154-0 |
0.398 |
|
| 1991 |
Szabo A, Dalmau J, Manley G, Rosenfeld M, Wong E, Henson J, Posner JB, Furneaux HM. HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal. Cell. 67: 325-33. PMID 1655278 DOI: 10.1016/0092-8674(91)90184-Z |
0.378 |
|
| Show low-probability matches. |